In the shadow of President Trump's efforts to lower drug prices, the Medicare drug price negotiation process that began in ...

Amgen Q1 2025 results beat estimates with strong product growth. Stay updated on tariff risks and drug pricing impacts.

The prices charged at the US launch of targeted cancer therapies have increased well above the rate of inflation every year since 2012.